EDITORIAL COMMENTARYIs Quinidine the Ideal Drug for Brugada Syndrome?
Section snippets
Acknowledgment
I thank Dr. S. Serge Barold (Tampa, FL) for helpful comments.
References (16)
- et al.
Right bundle branch block, persistent ST-segment elevation and sudden cardiac death
J Am Coll Cardiol
(1992) - et al.
Hydroquinidine therapy in Brugada syndrome
J Am Coll Cardiol
(2004) - et al.
Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation
Heart Rhythm
(2007) - et al.
Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome
Heart Rhythm
(2008) - et al.
Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review
Heart Rhythm
(2012) - et al.
Brugada syndrome: report of the second consensus conference
Heart Rhythm
(2005) - et al.
The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option?
Pacing Clin Electrophysiol
(2002) - et al.
Effects of electrophysiologic-guided therapy with class 1A antiarrhythmic drugs on long-term outcome in patients with idiopathic ventricular fibrillation and the Brugada syndrome
J Cardiovasc Electrophysiol
(1999)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.